Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Themis Medicare Ltd
Themis Medicare Ltd

Themis Medicare Ltd (THEMISMED) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 40,608
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹105.79
₹-0.66 (-0.62%)
104.21Low
Today’s Performance
107.04High
98.00Low
52 Week’s Performance
297.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-0.62%
  • 1 Week-1.92%
  • 1 Month-10.57%
  • 3 Months5.47%
  • 6 Months-23.54%
  • 1 Year-63.17%
  • 3 Years-0.19%
  • 5 Years22.52%

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta2.03
  • 52-Week Low (₹)98.00
  • 52-Week High (₹)297.00
  • Price-to-Book (X)*2.80
  • Dividend Yield (%)0.47
  • Price-to-Earnings (P/E) (X)*-36.04
  • Earnings Per Share (₹)-2.93
  • Market Cap (₹ Cr.)*973.69
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Will Pharma & Hospitals Lead Markets in 2026? | Portfolio Strategy Revealed2:37Will Pharma & Hospitals Lead Markets In 2026? | Portfolio Strategy Revealed
Can India Sustain 8%+ Growth? Inflation and other Challenges Explained2:30Can India Sustain 8%+ Growth? Inflation And Other Challenges Explained
"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
View more

bt_logoFAQ's

What was Themis Medicare Ltd share price previously?
Themis Medicare Ltd share price was down by -0.62% from the previous closing price of ₹106.45.
Who are peers of Themis Medicare Ltd?
The peers of Themis Medicare Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Themis Medicare Ltd?
The promotor/promotors of Themis Medicare Ltd are Dinesh S Patel, Sachin D Patel, Reena S Patel, Rajneesh Anand, Adam Demeter, Bhaskar Vemban Iyer, Shishir Dalal, Nikunt Raval, Neha Thakore.
What has been 52-week high of Themis Medicare Ltd stocks?
The highest price of Themis Medicare Ltd stock is ₹297.00 in the last 52-week.
What is the share price of Themis Medicare Ltd (THEMISMED) today on NSE?
As on Dec 05, 2025 Themis Medicare Ltd (THEMISMED)’s share price on NSE is Rs 105.79
What is the market cap of Themis Medicare Ltd (THEMISMED)?
The current market capitalisation of Themis Medicare Ltd (THEMISMED) is 973.69 crores
What is Themis Medicare Ltd Share symbol?
The symbol of Themis Medicare Ltd is THEMISMED.
What is the PE ratio of Themis Medicare Ltd (THEMISMED)?
The current PE ratio of Themis Medicare Ltd (THEMISMED) is -36.04.
What is the PB ratio of Themis Medicare Ltd (THEMISMED)?
The current PB ratio of Themis Medicare Ltd (THEMISMED) is 2.80.
Today’s High & Low share prices of Themis Medicare Ltd (THEMISMED) on NSE?
Today, the share price of Themis Medicare Ltd (THEMISMED) on NSE touched a high of Rs 107.04 and a low of Rs 104.21
What price did Themis Medicare Ltd (THEMISMED) shares open on the NSE today?
On NSE, the share price of Themis Medicare Ltd (THEMISMED) opened at Rs 106.05
What is the 52-week high of Themis Medicare Ltd (THEMISMED)?
The 52-week high price of Themis Medicare Ltd (THEMISMED) is Rs 297.00
What is the 52-week low of Themis Medicare Ltd (THEMISMED)?
The 52-week low price of Themis Medicare Ltd (THEMISMED) is Rs 98.00

bt_logoAbout Themis Medicare

Themis Medicare Ltd, incorporated in the year 1969, has its registered office in Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195, 91-260-2421675, 91-260-2430219. The main industry in which Themis Medicare Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Themis Medicare Ltd is/are Krishaan & Co. In the main management, Dinesh S Patel is chairman and is the company secretary for Themis Medicare Ltd.

  • DSP
    Dinesh S PatelChairman & Exec. Director
  • SDP
    Sachin D PatelED / MD / CEO / Promoter
  • RSP
    Reena S PatelNon-Exec & Non-Independent Dir
  • RA
    Rajneesh AnandNon-Exec & Non-Independent Dir
  • AD
    Adam DemeterNon-Exec & Non-Independent Dir
  • BVI
    Bhaskar Vemban IyerIndependent Non Exe. Director
  • SD
    Shishir DalalIndependent Non Exe. Director
  • NR
    Nikunt RavalIndependent Non Exe. Director
  • NT
    Neha ThakoreIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.